U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036159) titled 'A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months' on June 16.
Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of reduced antigen doses and alternative vaccination regimes for RTS,S/AS01E in healthy children aged 5-60 months in a malaria-endemic area.
Study Start Date: June 18
Study Type: INTERVENTIONAL
Condition:
Malaria
Intervention:
BIOLOGICAL: RTS,S/AS01E vaccine
RTS,S/AS01E vaccine will be administered intramuscularly.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: GlaxoSmithKline
Published by HT Digital Content Serv...